Oxidative Stress Mediates a Reduced Expression of the Activating Receptor NKG2D in NK Cells From End-Stage Renal Disease Patients

Journal of Immunology - United States
doi 10.4049/jimmunol.182.3.1696
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

Decreased NKG2D Expression on NK Cells Correlates With Impaired NK Cell Function in Patients With Gastric Cancer

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2011English

Pericardial Effusion in Patients With End-Stage Renal Disease

Texas Heart Institute Journal
MedicineCardiovascular MedicineCardiology
2015English

Pulmonary Hypertension in Patients With End-Stage Renal Disease

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2003English

HIV Testing in Patients With End Stage Renal Disease.

BMJ
1990English

Periodontal Disease in Chronic Kidney Disease and End-Stage Renal Disease Patients: A Review

CardioRenal Medicine
UrologyCardiovascular MedicineCardiology
2013English

The Perspectives of Patients With Lithium-Induced End-Stage Renal Disease

International Journal of Bipolar Disorders
PsychiatryMental HealthBiological Psychiatry
2018English

Renal Cell Carcinoma in End-Stage Renal Disease

2015English

Lipoprotein(a) Accelerated the Progression of Atherosclerosis in Patients With End-Stage Renal Disease

BMC Nephrology
Nephrology
2018English

Regulation of Ligands for the NKG2D Activating Receptor

Annual Review of Immunology
AllergyImmunology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy